Genetic testing for cardiac arrhythmias: Ready for prime time?

Steven J. Fowler, Raffaella Bloise

Research output: Contribution to journalArticlepeer-review


Despite the heterogeneity of substrates and clinical expressivity, genetic testing has a direct impact on clinical practice: it allows a specific diagnosis, including silent carriers (ie, asymptomatic diagnosis) and, in select diseases, the identification of a mutation has major impact for risk stratification and treatment of patients. This article addresses the role of genetic testing for each of the most epidemiologically relevant inherited arrhythmogenic diseases, specifically long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy.

Original languageEnglish
Pages (from-to)611-621
Number of pages11
JournalCardiac Electrophysiology Clinics
Issue number4
Publication statusPublished - Dec 2010


  • Arrhythmias
  • Cardiac
  • Channelopathies
  • Genetics
  • Multidisciplinary approach

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)


Dive into the research topics of 'Genetic testing for cardiac arrhythmias: Ready for prime time?'. Together they form a unique fingerprint.

Cite this